To give socialized training for all personnel (doctors, nurses and healthcare workers) involved in vaccination programmes.

To have adequate services regarding: accessibility of vaccine supplies, particularly of vaccine itself, vaccine record cards and registration materials and vaccine information sheets.

To provide a venue for research regarding the new emerging vaccines, its efficacy, surveillance, compliance and adverse reactions.

To facilitate discussions regarding problems as well as updates on the current vaccination status in the country.

To coordinate with other concerned agencies regarding its information education dissemination.

Community and Hospital Burden of Norovirus Disease in Children.

Phase III, Double-Blind, Randomized, Placebo-Controlled Trial to Investigate the Efficacy, Safety and Immunogenicity of a Tetravalent Dengue Vaccine (TDV) Administered Subcutaneously in Healthy Children Aged 4-16 Years Old.

Immunogenicity and Safety of Tetravalent Dengue Vaccine Given in 1-, 2-, or 3- Dose Schedules (STAGE I) Followed by a Single Booster Injection of the Same Vaccine (STAGE II) 1 or 2 Years after the Last Primary Dose in Healthy Subjects 9 to 50 Years of Age in Colombia and Philippines.